What Happened?
South San Fransico, CA-based Tizona-Therapeutics Appointed Christine Brien as Chief Executive Officer
About the Company
Tizona Therapeutics, Inc. is a preclinical stage biotechnology company that is developing multiple, innovative immuno-oncology therapies. Tizona Therapeutics, Inc. was founded by MPM Capital and leading scientists from Dana Farber Cancer Institute, the University of Pittsburgh, Johns Hopkins, Memorial Sloan Kettering Cancer Center, and Brigham and Women`s Hospital.
About the Person
Christine Brien is Chief Executive Officer at Tizona Therapeutics. Previously, Christine held various senior HR leadership roles in the industry.
Info Source
News
Short Profile